pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Irritable Bowel Syndrome in 2 studies
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.
Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rong, W | 1 |
| Keating, C | 1 |
| Sun, B | 1 |
| Dong, L | 1 |
| Grundy, D | 1 |
| Galligan, JJ | 1 |
1 review available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Enteric P2X receptors as potential targets for drug treatment of the irritable bowel syndrome.
Topics: Animals; Drug Delivery Systems; Enteric Nervous System; Humans; Irritable Bowel Syndrome; Pyridoxal | 2004 |
1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Purinergic contribution to small intestinal afferent hypersensitivity in a murine model of postinfectious bowel disease.
Topics: Adenosine Triphosphate; Animals; Fluorescent Dyes; Hypersensitivity; Intestine, Small; Irritable Bow | 2009 |